These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 34101770)

  • 1. COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing.
    Peto T;
    EClinicalMedicine; 2021 Jun; 36():100924. PubMed ID: 34101770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study.
    Eyre DW; Futschik M; Tunkel S; Wei J; Cole-Hamilton J; Saquib R; Germanacos N; Dodgson AR; Klapper PE; Sudhanva M; Kenny C; Marks P; Blandford E; Hopkins S; Peto TEA; Fowler T
    Lancet Infect Dis; 2023 Aug; 23(8):922-932. PubMed ID: 37001541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.
    Pickering S; Batra R; Merrick B; Snell LB; Nebbia G; Douthwaite S; Reid F; Patel A; Kia Ik MT; Patel B; Charalampous T; Alcolea-Medina A; Lista MJ; Cliff PR; Cunningham E; Mullen J; Doores KJ; Edgeworth JD; Malim MH; Neil SJD; Galão RP
    Lancet Microbe; 2021 Sep; 2(9):e461-e471. PubMed ID: 34226893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid antigen testing for SARS-CoV-2 by lateral flow assay: A field evaluation of self- and professional testing at UK community testing sites.
    Futschik ME; Johnson S; Turek E; Chapman D; Carr S; Thorlu-Bangura Z; Klapper PE; Sudhanva M; Dodgson A; Cole-Hamilton JR; Germanacos N; Kulasegaran-Shylini R; Blandford E; Tunkel S; Peto T; Hopkins S; Fowler T
    J Clin Virol; 2024 Apr; 171():105654. PubMed ID: 38387136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the sensitivity and specificity of lateral flow devices in the detection of SARS-CoV-2.
    Mistry DA; Wang JY; Moeser ME; Starkey T; Lee LYW
    BMC Infect Dis; 2021 Aug; 21(1):828. PubMed ID: 34407759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world evaluation of rapid and laboratory-free COVID-19 triage for emergency care: external validation and pilot deployment of artificial intelligence driven screening.
    Soltan AAS; Yang J; Pattanshetty R; Novak A; Yang Y; Rohanian O; Beer S; Soltan MA; Thickett DR; Fairhead R; Zhu T; Eyre DW; Clifton DA;
    Lancet Digit Health; 2022 Apr; 4(4):e266-e278. PubMed ID: 35279399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing lateral flow testing with a rapid RT-PCR method for SARS-CoV-2 detection in the United Kingdom-A retrospective diagnostic accuracy study.
    Taylor A; Calvez R; Atkins M; Fink CG
    Health Sci Rep; 2022 Sep; 5(5):e811. PubMed ID: 36177402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent Transmission.
    Lee LYW; Rozmanowski S; Pang M; Charlett A; Anderson C; Hughes GJ; Barnard M; Peto L; Vipond R; Sienkiewicz A; Hopkins S; Bell J; Crook DW; Gent N; Walker AS; Peto TEA; Eyre DW
    Clin Infect Dis; 2022 Feb; 74(3):407-415. PubMed ID: 33972994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More than the Eye Can See: Shedding New Light on SARS-CoV-2 Lateral Flow Device-Based Immunoassays.
    Koller G; Morrell AP; Galão RP; Pickering S; MacMahon E; Johnson J; Ignatyev K; Neil SJD; Elsharkawy S; Fleck R; Machado PMP; Addison O
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25694-25700. PubMed ID: 34048220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world deployment of lateral flow SARS-CoV-2 antigen detection in the emergency department to provide rapid, accurate and safe diagnosis of COVID-19.
    Merrick B; Noronha M; Batra R; Douthwaite S; Nebbia G; Snell LB; Pickering S; Galao RP; Whitfield J; Jahangeer A; Gunawardena R; Godfrey T; Laifa R; Webber K; Cliff PR; Cunningham E; Neil SJD; Gettings H; Edgeworth JD; Harrison HL
    Infect Prev Pract; 2021 Dec; 3(4):100186. PubMed ID: 34812417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis.
    Lamb G; Heskin J; Randell P; Mughal N; Moore LS; Jones R; Davies GW; Rayment M
    J Infect; 2021 Oct; 83(4):452-457. PubMed ID: 34364950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study.
    Pallett SJC; Rayment M; Patel A; Fitzgerald-Smith SAM; Denny SJ; Charani E; Mai AL; Gilmour KC; Hatcher J; Scott C; Randell P; Mughal N; Jones R; Moore LSP; Davies GW
    Lancet Respir Med; 2020 Sep; 8(9):885-894. PubMed ID: 32717210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial.
    Love NK; Ready DR; Turner C; Verlander NQ; French CE; Martin AF; Sorensen TB; Metelmann S; Denford S; Rubin GJ; Yardley L; Amlôt R; Hopkins S; Oliver I
    Lancet Respir Med; 2022 Nov; 10(11):1074-1085. PubMed ID: 36228640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who is accessing community lateral flow device testing and why? Characteristics and motivations of individuals participating in COVID-19 community testing in two English local authority areas.
    Dalili MN; Long J; Wadley E; Sloan J; Cross A; Thomas KH; Morgan G
    BMC Public Health; 2022 Mar; 22(1):588. PubMed ID: 35337297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.